Published online before print November 6, 2006, doi: 10.1161/CIRCULATIONAHA.106.631465
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:2261-2270.)
© 2006 American Heart Association, Inc.
Molecular Cardiology |
Estrogen Receptors 
and ß Mediate Contribution of Bone Marrow–Derived Endothelial Progenitor Cells to Functional Recovery After Myocardial Infarction
From the Division of Cardiovascular Research, St Elizabeth Medical Center of Boston, Tufts University School of Medicine, Boston, Mass (H.H., M.K.K., A.I., M.I., T.T., G.Q., J.A., Y.T., H.S., M.S., A.W., E.B., Y.Z., R.K., D.W.L.), and Stem Cell Translational Research, Kobe Institute of Biomedical Research and Innovation/RIKEN Center for Developmental Biology, Kobe, Japan (M.I.).
Correspondence to Douglas W. Losordo, MD, Cardiovascular Research, Caritas St. Elizabeth Medical Center of Boston, 736 Cambridge St, Boston, MA 02135. E-mail douglas.losordo{at}tufts.edu
Received April 3, 2006; revision received July 6, 2006; accepted August 11, 2006.
Background— Estradiol (E2) modulates the kinetics of circulating endothelial progenitor cells (EPCs) and favorably affects neovascularization after ischemic injury. However, the roles of estrogen receptors 
(ER) and ß (ERß) in EPC biology are largely unknown.
Methods and Results— In response to E2, migration, tube formation, adhesion, and estrogen-responsive element–dependent gene transcription activities were severely impaired in EPCs obtained from ER-knockout mice (ERKO) and moderately impaired in ERßKO EPCs. The number of ERKO EPCs (42.4±1.5; P<0.001) and ERßKO EPCs (55.4±1.8; P=0.03) incorporated into the ischemic border zone was reduced as compared with wild-type (WT) EPCs (72.5±1.3). In bone marrow transplantation (BMT) models, the number of mobilized endogenous EPCs in E2-treated mice was significantly reduced in ERKO BMT (WT mice transplanted with ERKO bone marrow) (2.03±0.18%; P=0.004 versus WT BMT) and ERßKO BMT (2.62±0.07%; P=0.02 versus WT) compared with WT BMT (2.87±0.13%) (WT to WT BMT as control) mice. Capillary density at the border zone of ischemic myocardium also was significantly reduced in ERKO BMT and ERßKO BMT compared with WT mice (WT BMT, 1718±75/mm2; ERKO BMT, 1107±48/mm2; ERßKO BMT, 1567±50/mm2). ER mRNA was expressed more abundantly on EPCs compared with ERß. Moreover, vascular endothelial growth factor was significantly downregulated on ERKO EPCs compared with WT EPCs both in vitro and in vivo.
Conclusions— Both ER and ERß contribute to E2-mediated EPC activation and tissue incorporation and to preservation of cardiac function after myocardial infarction. ER plays a more prominent role in this process. Moreover, ER contributes to upregulation of vascular endothelial growth factor, revealing possible mechanisms of an effect of E2 on EPC biology. Finally, these data provide additional evidence of the importance of bone marrow–derived EPC phenotype in ischemic tissue repair.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  E. A. Jankowska, P. Rozentryt, B. Ponikowska, O. Hartmann, D. Kustrzycka-Kratochwil, K. Reczuch, J. Nowak, L. Borodulin-Nadzieja, L. Polonski, W. Banasiak, et al. Circulating Estradiol and Mortality in Men With Systolic Chronic Heart Failure JAMA, May 13, 2009; 301(18): 1892 - 1901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Balligand, O. Feron, and C. Dessy eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues Physiol Rev, April 1, 2009; 89(2): 481 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.O. Robb, N.L. Mills, I.B.J. Smith, A. Short, O. Tura-Ceide, G.R. Barclay, A. Blomberg, H.O.D. Critchley, D.E. Newby, and F.C. Denison Influence of menstrual cycle on circulating endothelial progenitor cells Hum. Reprod., March 1, 2009; 24(3): 619 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-P. T Ruifrok, R. A de Boer, A. Iwakura, M. Silver, K. Kusano, R. A Tio, and D. W Losordo Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia Vascular Medicine, February 1, 2009; 14(1): 29 - 36. [Abstract] [PDF]
|
|
|
|
 |
|
 T. A. Markel, Y. Wang, J. L. Herrmann, P. R. Crisostomo, M. Wang, N. M. Novotny, C. M. Herring, J. Tan, T. Lahm, and D. R. Meldrum VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2308 - H2314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Markel, P. R. Crisostomo, M. Wang, Y. Wang, T. Lahm, N. M. Novotny, J. Tan, and D. R. Meldrum TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1124 - R1130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Suriano, D. Chaudhuri, R. S. Johnson, E. Lambers, B. T. Ashok, R. Kishore, and R. K. Tiwari 17{beta}-Estradiol Mobilizes Bone Marrow-Derived Endothelial Progenitor Cells to Tumors Cancer Res., August 1, 2008; 68(15): 6038 - 6042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zhan, T. Keimig, J. Xu, E. Peterson, J. Ding, F. Wang, and X.-P. Yang Dose-dependent cardiac effect of oestrogen replacement in mice post-myocardial infarction Exp Physiol, August 1, 2008; 93(8): 982 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. C Villar, A. J Hobbs, and A. Ahluwalia Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor J. Endocrinol., June 1, 2008; 197(3): 447 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Miller and S. P. Duckles Vascular Actions of Estrogens: Functional Implications Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Fadini, S. de Kreutzenberg, M. Albiero, A. Coracina, E. Pagnin, I. Baesso, A. Cignarella, C. Bolego, M. Plebani, G. B. Nardelli, et al. Gender Differences in Endothelial Progenitor Cells and Cardiovascular Risk Profile: The Role of Female Estrogens Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 997 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ray, C. M. Herring, T. A. Markel, P. R. Crisostomo, M. Wang, B. Weil, T. Lahm, and D. R. Meldrum Deleterious effects of endogenous and exogenous testosterone on mesenchymal stem cell VEGF production Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1498 - R1503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mieno, R. T. Clements, M. Boodhwani, N. R. Sodha, B. Ramlawi, C. Bianchi, and F. W. Sellke Characteristics and Function of Cryopreserved Bone Marrow-Derived Endothelial Progenitor Cells Ann. Thorac. Surg., April 1, 2008; 85(4): 1361 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Balestrieri, C. Schiano, F. Felice, A. Casamassimi, A. Balestrieri, L. Milone, L. Servillo, and C. Napoli Effect of Low Doses of Red Wine and Pure Resveratrol on Circulating Endothelial Progenitor Cells J. Biochem., February 1, 2008; 143(2): 179 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D. Nelson, A. G. Zenovich, H. C. Ott, C. Stolen, G. J. Caron, A. Panoskaltsis-Mortari, S. A. Barnes III, X. Xin, and D. A. Taylor Sex-Dependent Attenuation of Plaque Growth After Treatment With Bone Marrow Mononuclear Cells Circ. Res., December 7, 2007; 101(12): 1319 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Masuda, C. Kalka, T. Takahashi, M. Yoshida, M. Wada, M. Kobori, R. Itoh, H. Iwaguro, M. Eguchi, Y. Iwami, et al. Estrogen-Mediated Endothelial Progenitor Cell Biology and Kinetics For Physiological Postnatal Vasculogenesis Circ. Res., September 14, 2007; 101(6): 598 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Dawn and R. Bolli Increasing Evidence That Estrogen Is an Important Modulator of Bone Marrow-Mediated Cardiac Repair After Acute Infarction Circulation, November 21, 2006; 114(21): 2203 - 2205. [Full Text] [PDF]
|
|